Tackling Diabetic Kidney Disease: Breakthroughs in Treatment
Published: Mar 19, 2024
Diabetic kidney disease requires effective treatment strategies to prevent progression. Explore the latest breakthroughs and therapies available.
Contents
Role of SGLT2 Inhibitors
SGLT2 inhibitors are a class of medications showing promise in treating diabetic kidney disease. These drugs help protect the kidneys by reducing the workload on them, similar to unloading a heavy backpack from your shoulders. By decreasing sugar reabsorption in the kidneys, they help slow down kidney damage over time.
The Power of ACE Inhibitors
ACE inhibitors are another vital therapy in managing diabetic kidney disease. They work by relaxing blood vessels, which lowers blood pressure and reduces stress on the kidneys. Imagine easing the pressure on a garden hose to prevent it from bursting—this is how ACE inhibitors help protect your kidneys.
Frequently Asked Questions
They are drugs that help protect kidneys by reducing sugar reabsorption.
They lower blood pressure and reduce kidney stress.
Yes, they help slow down kidney damage in diabetes.
They can help manage and slow the progression, but not entirely prevent it.
Key Takeaways
Advancements in therapy offer hope for better management of diabetic kidney disease.
Interested in learning more about these treatments? Doctronic has the answers you need.Related Articles
References
Heerspink HJL, Kosiborod M, Inzucchi SE, Cherney DZI. Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. Kidney Int 2018; 94:26.
Bakris GL. Major Advancements in Slowing Diabetic Kidney Disease Progression: Focus on SGLT2 Inhibitors. Am J Kidney Dis 2019; 74:573.
Always discuss health information with your healthcare provider.